(Q41616767)

English

Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

0 references

fluticasone propionate

1 reference

based on heuristic

inferred from title

author name string

Galant SP

1

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

van Bavel J

2

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

Finn A

3

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

Gross G

4

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

Pleskow W

5

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

Brown A

6

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

Hamedani AG

7

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

Harding SM

8

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

publication date

1 March 1999

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

Annals of Allergy, Asthma & Immunology

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

82

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

273-280

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

The human pharmacology of fluticasone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Use and misuse of metered-dose inhalers by patients with chronic lung disease. A controlled, randomized trial of two instruction methods

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The Diskus: a new multi-dose powder device--efficacy and comparison with Turbuhaler

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled corticosteroids: benefits and risks

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Diurnal cortisol secretion during therapy with inhaled beclomethasone dipropionate in children with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Integrated plasma cortisol concentration in children with asthma receiving long‐term inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1081-1206(10)62608-7

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41616767&oldid=1925093068"